Companies To Watch: Obesity drugs, GLP-1s & pharma’s next billion-dollar bet

from Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek · host MONEY FM 89.3

Big Pharma just rewrote the rulebook in the obesity-treatment race. Pfizer has won the bidding for Metsera after a showdown with Novo Nordisk. Dan Koh and Emaad Akhtar unpack how this US$10 billion move signals a pivot into GLP-1 drugs, why Novo walked away and what it all means for investors tracking the next trillion-dollar health-tech frontier.See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Nov 13, 2025

Embed this episode

Attribution link and audio player

Ready to play

Companies To Watch: Obesity drugs, GLP-1s & pharma’s next billion-dollar bet

0:00 11:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek?

This episode is 11 minutes long.

When was this Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek episode published?

This episode was published on November 13, 2025.

Can I download this Breakfast with Ryan Huang, Emaad Akhtar and Audrey Siek episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!